Related Articles
Proliferating cell nuclear antigen labeling index and p53 expression predict outcome for breast cancer patients with four or more lymph node metastases
Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients
Clinicopathological features and treatment sensitivity of elderly Chinese breast cancer patients
PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AND C-ERBB-2 ONCOPROTEIN IN BREAST-CARCINOMA WITH CORRELATIONS TO HISTOPATHOLOGICAL PARAMETERS AND PROGNOSIS
Prognosis of lymph node‑negative breast cancer: Association with clinicopathological factors and tumor associated gene expression